NorthWest Biotherapeutics Inc (NWBO)

[Bright Boy]

Sojo,

The OTC is definitely a major issue with Northwest trading and SP, but the real issue is that new buyers are "traders" only. New buyers don't want to "own" the stock, because of lack of available information. New buyers just want to trade the stock.Again, call any brokerage firm in America and ask about NWBO. IF they're willing to respond, they'll tell you,"We've have no research on the company and besides, it's an OTC stock and we cannot buy." 100% of the buyers are using their own accounts at TD Ameritrade, Fidelity.... and are buying for a "long shot" trade, not to buy and hold. The long term buyers are already in and most of them acquired shares from the company through various financings. Northwest needs to "do a deal" if they expect any kind of investment banking interest. A transaction supported by an underwriter generates a myriad of "fee for services" opportunities for the lead underwriter/investment banker ie;"Fairness Opinions, Resource Analysis ..... which is the only reason any banker would look twice at any company!! "Pay me, Pay me,Pay me and then Pay me some more." And even then you'll never receive the kind of support that you think you deserve!!! Retail demand is the real hope for a reasonable SP and Northwest will get that if they have exceptional demand for their breakthrough technology in cancer treatment. All the other stuff that we are seeing on the board ie; Reverse Splits..... are just gimmicks and don't create value. All they do is create an opportunities to sell into the initial bump. IF the technology works, a "team of wild horses" couldn't drag buyers away from Northwest and no matter where it's traded, buyers will find it!!! Northwest wants these different exchanges to "BEG" them to list.:"Chasing" never succeeds!!!!!